Curative effect of Ranibizumab combined with laser photocoagulation for proliferative diabetic retinopathy
Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 18, Issue 4
Abstract
AIM:To investigate the clinical efficacy of Ranibizumab combined with laser photocoagulation in the treatment of proliferative diabetic retinopathy(PDR). <p>METHODS: Totally 80 patients(101 eyes)with PDR admitted to our hospital from October 2014 and October 2016 were selected and divided into the observation group and the control group, with 50 eyes and 51 eyes respectively. The patients in the control group(50 eyes)were treated with panretinal photocoagulation(PRP), and the patients in observation group(51 eyes)were treated with ranibizumab on the basis of PRP treatment. Best corrected visual acuity(BCVA)was compared before and after surgery 1, 3, and 6mo. Optical coherence tomography(OCT)was used to examine the central macular thickness(CMT)and the area of neovascularization at each timepoints. Then the laser spot number, laser energy and energy density were compared between the two groups and the adverse reactions were recorded. <p>RESULTS: Postoperative BCVA of the two groups significantly increased, and the BCVA of observation group were significantly higher than that of the control group after surgery 1, 3, 6mo, the difference was statistically significant(<i>P</i><0.05). After treatment, the CMT and neovascularization area of the two groups significantly decreased, and those of the observation group were significantly lower than those of the control group after surgery 1, 3, 6mo, the difference was statistically significant(<i>P</i><0.05). The laser spot number, laser energy and energy density of the observation group were significantly lower than those of the control group, the difference was statistically significant(<i>P</i><0.05). There were 2 cases(2 eyes)in the observation group and 1 cases(1 eye)in the control group, whose intraocular pressure exceeded 28mmHg, while relieved rapidly after the treatment, and no obvious complications occurred in two groups. <p>CONCLUSION: Ranibizumab combined with laser in the treatment of PDR is an effective and safe way to improve BCVA, reduce CMT, and eliminate new blood vessels with less required laser energy.
Authors and Affiliations
Fan-Yi Meng
Keywords
Related Articles
- EP ID EP656095
- DOI 10.3980/j.issn.1672-5123.2018.4.10
- Views 111
- Downloads 0
Measurement of RNFL thickness in the normals and open angle glaucoma patients by OCT
AIM: To investigate the retinal nerve fiber layer thickness(RNFL)in normal subjects and primary open angle glaucoma(POAG)patients by optical coherence tomography(OCT), and to provide a theoretical basis for the diagnosis...
Research progress in physical therapy for dry eye
Dry eye is a common ocular surface disease, which seriously affects the work and quality of life of the patients. In recent years, physical therapies for dry eye have developed rapidly. This paper summarizes the traditio...
Comparison of posterior capsule folds following intracapsular implantation of three types of intraocular lenses with different haptic design
AIM: To compare the incidence of posterior capsule folds among different types of intraocular lens(IOL)to determine risk factors of posterior capsule folds. <p>METHODS:It was a retrospective study. We collected the cases...
Clinical effect of levodopa and benserazide hydrochloride tables combined with visual occlusion for amblyopia in children
AIM:To study the therapeutic effect of visual occlusion combined with levodopa and benserazide hydrochloride tables on children with amblyopia. <p>METHODS: Totally 90 cases(140 eyes)of children diagnosed with amblyopia i...
Soft corneal contact lens for postoperative comfort in patients with recurrent pterygium function
AIM:To evaluate the effect of soft contact lens on the comfort of postoperative patients with recurrent pterygium. <p>METHODS: For 100 eyes of 98 patients after recurrent pterygium excision, the conjunctival implant with...